The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
This marks the first multicenter, randomized phase 3 trial in over two decades to meet such endpoints in localized prostate cancer, potentially redefining treatment for patients seeking curative ...
NEEDHAM, Mass. - Candel Therapeutics, Inc. (NASDAQ:CADL), a clinical-stage biotechnology company with a market capitalization of $304 million, announced Monday that its experimental cancer treatment ...
NEEDHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal ...
Candel’s recent phase 1b trial in high-grade glioma also indicated a favorable safety profile and potential survival benefits, though CAN-2409 is not currently prioritized for this indication. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results